IP Library Granted Patent US 8,679,491
Granted Patent B2
US 8,679,491 · App. 12/645,613 · Granted Mar 25, 2014

Method of modulating the activity of functional immune molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,491
App. No.
12/645,613
Granted
Mar 25, 2014
Kind
B2
Abstract

The invention relates to a method for controlling the activity of an immunologically functional molecule, such as an antibody, a protein, a peptide or the like, an agent of promoting the activity of an immunologically functional molecule, and an immunologically functional molecule having the promoted activity.

Claims (8)

1. A method of increasing antibody-dependent cellular cytotoxicity (ADCC) in a composition comprising IgG antibodies, said method comprising increasing an amount of at least one antibody selected from (a) and (b), wherein the antibody has two complex N-glycoside-linked sugar chains in a Fc region:

(a) the antibody has two complex N-glycoside-linked sugar chains in which fucose is not bound, and

(b) the antibody has one of the complex N-glycoside-linked sugar chain in which fucose is not bound and one of the complex N-glycoside-linked sugar chain in which fucose is bound; and

measuring ADCC activity of said composition.

2. A method for increasing the antibody-dependent cellular cytotoxicity (ADCC) of antibodies produced by a cell, comprising manipulating said cell to increase the proportion of an antibody selected from (a) and (b) produced by said cell, or comprising manipulating antibodies produced by said cell to increase the proportion of an antibody selected from (a) and (b):

(a) an antibody having two complex N-glycoside-linked sugar chains in its Fc region to which fucose is not bound; and

(b) an antibody having two complex N-glycoside-linked sugar chains in its Fc region, in which fucose is bound to one of said complex N-glycoside-linked sugar chains and fucose is not bound to the other of said complex N-glycoside-linked sugar chains; and

measuring ADCC activity of said antibody.

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →